國立高雄大學圖資館 |

Language: English

Back

Bone regulators and osteoporosis therapy

SpringerLink (Online service)

Bone regulators and osteoporosis therapy

Record Type:	Electronic resources : Monograph/item
Title/Author:	Bone regulators and osteoporosis therapyedited by Paula H. Stern.
other author:	Stern, Paula H.
Published:	Cham :Springer International Publishing :2020.
Description:	x, 518 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	OsteoporosisTreatment.
Online resource:	https://doi.org/10.1007/978-3-030-57378-2
ISBN:	9783030573782$q(electronic bk.)

Bone regulators and osteoporosis therapy
Bone regulators and osteoporosis therapy[electronic resource] /edited by Paula H. Stern. - Cham :Springer International Publishing :2020. - x, 518 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2620171-2004 ;. - Handbook of experimental pharmacology ;208..

The cells of bone their interactions -- Parathyroid hormone and bone -- Vitamin D and bone -- Gonadal hormones and bone -- Thyroid hormones, glucocorticoids, insulin, and bone -- Growth factors and bone -- Prostaglandins and bone -- Cytokines and bone: osteoimmunology -- Chemokines and bone -- Calcium and bone -- FGF-23 and bone and mineral metabolism -- Nervous system mediators and bone -- Genetics of bone disorders -- Osteoporosis pathogenesis -- Structural and metabolic assessment of bone status -- Osteoporosis Therapeutics 2019 -- New targets and emergent therapies for osteoporosis -- Drugs causing bone loss -- Natural Products as potential bone therapies.

This volume is designed to provide an understanding of current and potential therapies for osteoporosis. The opening chapter introduces the cells of bone and their interactions. Several following chapters describe factors affecting bone including systemic hormones with significant effects on bone, and local mediators including growth factors, prostaglandins, cytokines and chemokines. Topics that have commanded particular attention recently are calcium, FGF-23, nervous system bone interactions. Drugs that cause bone loss provide important information on mechanism as well as therapeutic considerations. An overview of the genetics of bone disorders and a discussion of the pathophysiology of osteoporosis establish the clinical context. The final chapters discuss current and potential osteoporosis treatments.

ISBN: 9783030573782$q(electronic bk.)

Standard No.: 10.1007/978-3-030-57378-2doiSubjects--Topical Terms:

318005
Osteoporosis
--Treatment.

LC Class. No.: RC931.O73

Dewey Class. No.: 616.716

Bone regulators and osteoporosis therapy
LDR:02527nmm a2200337 a 4500 001 589285
003 DE-He213
005 20210224163110.0
006 m d
007 cr nn 008maaau
008 210601s2020 sz s 0 eng d
020 $a 9783030573782$q(electronic bk.)
020 $a 9783030573775$q(paper)
024 7 $a 10.1007/978-3-030-57378-2 $2 doi
035 $a 978-3-030-57378-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC931.O73
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 616.716 $2 23
090 $a RC931.O73 $b B712 2020
245 0 0 $a Bone regulators and osteoporosis therapy $h [electronic resource] / $c edited by Paula H. Stern.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a x, 518 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.262
505 0 $a The cells of bone their interactions -- Parathyroid hormone and bone -- Vitamin D and bone -- Gonadal hormones and bone -- Thyroid hormones, glucocorticoids, insulin, and bone -- Growth factors and bone -- Prostaglandins and bone -- Cytokines and bone: osteoimmunology -- Chemokines and bone -- Calcium and bone -- FGF-23 and bone and mineral metabolism -- Nervous system mediators and bone -- Genetics of bone disorders -- Osteoporosis pathogenesis -- Structural and metabolic assessment of bone status -- Osteoporosis Therapeutics 2019 -- New targets and emergent therapies for osteoporosis -- Drugs causing bone loss -- Natural Products as potential bone therapies.
520 $a This volume is designed to provide an understanding of current and potential therapies for osteoporosis. The opening chapter introduces the cells of bone and their interactions. Several following chapters describe factors affecting bone including systemic hormones with significant effects on bone, and local mediators including growth factors, prostaglandins, cytokines and chemokines. Topics that have commanded particular attention recently are calcium, FGF-23, nervous system bone interactions. Drugs that cause bone loss provide important information on mechanism as well as therapeutic considerations. An overview of the genetics of bone disorders and a discussion of the pathophysiology of osteoporosis establish the clinical context. The final chapters discuss current and potential osteoporosis treatments.
650 0 $a Osteoporosis $x Treatment. $3 318005
650 0 $a Osteoporosis $x Pathophysiology. $3 379851
650 0 $a Bones $x Pathophysiology. $3 384701
650 0 $a Pharmacology. $3 218135
650 0 $a Cell physiology. $3 194355
650 0 $a Cytokines. $3 195178
650 0 $a Growth factors. $3 250597
650 0 $a Metabolism $x Disorders. $3 318679
650 0 $a Proteins. $3 193852
650 0 $a Endocrinology. $3 196517
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Cell Physiology. $3 238835
650 2 4 $a Cytokines and Growth Factors. $3 379480
650 2 4 $a Metabolic Diseases. $3 274217
650 2 4 $a Receptors. $3 337756
700 1 $a Stern, Paula H. $3 881120
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u https://doi.org/10.1007/978-3-030-57378-2
950 $a Biomedical and Life Sciences (SpringerNature-11642)